Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
NCT04383717
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Respiratory Tract Infections
Interventions
DRUG:
Levamisole and isoprinosine
DRUG:
Azithromycin and hydroxychloroquine
Sponsor
Cairo University